Allscripts Healthcare Solutions (NASDAQ:MDRX)‘s stock had its “neutral” rating reiterated by equities researchers at Citigroup Inc. in a research report issued on Friday. They currently have a $13.00 target price on the stock, down from their previous target price of $17.00. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) belongs to Technology sector. Its net profit margin is -7.90% and weekly performance is -15.89%. On last trading day company shares ended up $11.54. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) distance from 50-day simple moving average (SMA50) is -16.82%. Smartphone maker Nokia Corporation (ADR) (NYSE:NOK) has become both a friend and a foe to one-time nemesis Apple Inc when it comes to patents. Nokia, once the world’s largest smartphone maker, says US courts are going too far in rolling back intellectual property rights. In one case, it supports Apple’s right to block the sale of products that infringe patents. In another, it contends an appeals court was wrong to throw out a $368mn damage award against the iPhone maker. Nokia Corporation (ADR) (NYSE:NOK) shares fell -1.48% in last trading session and ended the day at $8.01. NOK Gross Margin is 43.70% and its return on assets is 6.60%. Nokia Corporation (ADR) (NYSE:NOK) quarterly performance is 3.76%. On Oct. 29, Falconstor Software Inc. (NASDAQ:FALC), announced that Michael P. Kelly has been elected to the FalconStor Board of Directors, bringing the total number of board members to eight. Currently, Mr. Kelly is also the CEO of Kinsale Associates and Chairman of the Board at Adept Technology, Inc. On 07 November, Falconstor Software Inc. (NASDAQ:FALC) shares fell -2.56% and was closed at $1.14. FALC EPS growth in last 5 year was -69.50%. Falconstor Software Inc. (NASDAQ:FALC) year to date (YTD) performance is -15.56%. On Oct. 20, Levi & Korsinsky notifies investors of LipoScience, Inc. (NASDAQ:LPDX) of claims breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to LabCorp. A complaint was filed in North Carolina state court. LipoScience, Inc. (NASDAQ:LPDX) ended the last trading day at $5.23. Company weekly volatility is calculated as 0.31% and price to cash ratio as 1.87. LipoScience, Inc. (NASDAQ:LPDX) showed a weekly performance of 0.19%. On Oct. 29, CenturyLink, Inc. (NYSE:CTL) and Alcatel-Lucent (nyse:ALU) announced that CenturyLink, the third largest telecommunications company in the U.S., has deployed the 7950 Extensible Routing System (XRS) to meet the growing data and video demands from its customer base across the United States. With the introduction of the 7950 XRS core router in its IP core network, CenturyLink obtains an end-to-end managed IP/MPLS network. CenturyLink, Inc. (NYSE:CTL) shares increased 1.10% in last trading session and ended the day at $39.43. CTL Gross Margin is 57.40% and its return on assets is -0.80%. CenturyLink, Inc. (NYSE:CTL) quarterly performance is -0.78%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
